AbstractAim: By employing 3% hydrogen peroxide (HP) as a scolicidal agent in PAIR therapy for the treatment of hepatic hydatid disease, the clinical outcomes and efficacy of the intervention will be assessed.
Materials and Method: Fifty Hydatid cysts were treated in forty patients via the PAIR procedure with 3% HP as a scolicidal agent. Clinical, radiological, and laboratory characteristics were documented prior to the procedure, as were post procedural morbidity, mortality, and duration of hospital stay.
Results: Fifty hydatid cysts were treated with PAIR in forty patients, yielding a success rate of ninety-five percent and no fatalities. The average duration of hospitalization was three days. Seven patients in our series experienced minor complications, while four patients encountered significant complications. The mean duration of the follow-up period was 15.3 months, ranging from 12 to 18 months. 2 patients experienced recurrence.
Conclusion: PAIR therapy is a minimally invasive approach utilized to treat hepatic hydatid lesions of the Gharbi type I-III. It is a relatively risk-free procedure that substantially shortens the length of hospitalization. It was our conviction that HP exerts some influence on the results and consequences of PAIR on its own.
